Citations

Clear

323 citation(s) found for "Mayer, Jiřı́".

Results of the PERSIST-1 phase III study of pacritinib (PAC) versus best available therapy (BAT) in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF), or post-essential thrombocythemia-myelofibrosis (PET-MF).
Egyed, Miklós , Szőke, Anita , Suvorov, Aleksandr , Mayer, Jiří , Jourdan, Éric , Schouten, Harry C. , Tosi, Patrizia , Dean, James , Cernohous, Paul, Nangalia, Jyoti , Harrison, Claire , Mesa, Ruben A. , Perkins, Andrew C. , Ganly, Peter S. , Farber, Charles Michael , Zachée, Pierre , Scheid, Christof , Kiladjian, Jean‐Jacques , Vannucchi, Alessandro M. , Mead, Adam J.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: LBA7006-LBA7006

10.1200/jco.2015.33.15_suppl.lba7006 Get It

Outcomes for FOLFIRI plus bevacizumab (BEV) or cetuximab (CET) in patients previously treated with oxaliplatin-based adjuvant therapy: A combined analysis of data from FIRE-3 and CALGB 80405.
Heinemann, Volker , Niedzwiecki, Donna , Pearline, Rachel V., Höchster, Howard S. , Goldberg, Richard M. , Innocenti, Federico , Schilsky, Richard L. , Blanke, Charles D. , Stinzing, Sebastian, O’Neil, Bert H. , Niedzwiecki, Donna , Grothey, Axel , Mayer, Robert J. , Bertagnolli, Monica M. , Venook, Alan P.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3585-3585

10.1200/jco.2015.33.15_suppl.3585 Get It

Clinical evaluation of germline polymorphisms (SNPs) associated with capecitabine (C) toxicity (tox) in metastatic breast cancer (MBC).
O’Donnell, Peter H. , Nurhussein-Patterson, Ashley, Huo, Dezheng , Morrow, Phuong K. , Storniolo, Anna Maria , Forero‐Torres, Andres , Poznak, Catherine Van , Merkel, Douglas E., Rosner, Gary L. , Ratain, Mark J. , Dolan, M. Eileen , Nanda, Rita , Trubetskoy, Vassily Vladimirovich , Hall, Julianne P. , Fleming, Gini F. , Ingle, James N. , Mayer, Ingrid A. , Olopade, Olufunmilayo I. , Cox, Nancy J.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 1049-1049

10.1200/jco.2015.33.15_suppl.1049 Get It

Breast Cancer, Version 3.2018
Gradishar, William J. , Anderson, Benjamin O. , Abraham, Jame , Aft, Rebecca , Allison, Kimberly H. , Blair, Sarah L. , Burstein, Harold J. , Dang, Chau T. , Farrar, William B., Goldstein, Lori J. , Isakoff, Steven J. , Lyons, Janice A., Moran, Meena S. , O'Regan, Ruth M., Patel, Sameer A. , Pierce, Lori J. , Reed, Elizabeth , Sitapati, Amy M. , Smith, Mary Lou , Telli, Melinda L. , Shead, Dorothy A. , Goetz, Matthew P. , Elias, Anthony , Giordano, Sharon H. , Marcom, Paul Kelly , Mayer, Ingrid A. , Mortimer, Joanne , Rugo, Hope S. , Smith, Karen L. , Soliman, Hatem Hussein , Ward, John Headley , Young, Jessica S. , Kumar, Rashmi , Telli, Melinda L

Mayo Clinic

Journal of the National Comprehensive Cancer Network | February 20, 2019 | Volume: 17 | Issue: 2 | Pages: 118-126

10.6004/jnccn.2019.0009 | PMID 30787125 Get It

These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor–positive, HER2-negative early-stage invasive breast cancer. This report summarizes these updates and discusses the rationale behind them.
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
Iranzo, Álex , Hu, Michele, Högl, Birgit , Manni, Raffaele , Oertel, Wolfgang H. , Arnulf, Isabelle , Puligheddu, Monica , Antelmi, Elena , Arnaldi, Dario , Mollenhauer, Brit , Šonka, Karel , Kunz, Dieter , Dauvilliers, Yves , Lewis, Simon J.G. , Heidbreder, Anna , Montplaisir, Jacques , Santamaría, Joan , Barber, Thomas R. , Stefani, Ambra , Louis, Erik K. St. , Janzen, Annette , Leu-Semenescu, Smandra, Sixel-Doering, F., Dušek, Petr , Bes, Frédérik , Gagnon, Jean‐François , Gaig, Carles , Zucconi, Marco , Trenkwalder, Claudia , Lo, Christine , Rolinski, Michal , Mahlknecht, Philipp , Holzknecht, Evi , Boeve, Angel R, Teigen, Luke, Toscano, Gianpaolo , Mayer, Geert , Morbelli, Silvia , Dawson, Benjamin, Pelletier, Amélie , Shulman, Joshua , St Louis, Erik K, Teigen, Luke N, St Louis, E K , Antelmi, Elena , Lewis, Simon J G , Dušek, Petr , Dauvilliers, Yves , Stefani, Ambra , Postuma, Ronald B. , Boeve, Bradley F. , Ferini-Strambi, Luigi , Cochen De Cock, Valérie , Videnovic, Aleksandar , Jung, Ki‐Young , Provini, Federica , Buskova, Jitka , Pavlova, Milena K. , Terzaghi, Michele , Leu‐Semenescu, Smaranda , Plazzi, Giuseppe , Nobili, Flavio Mariano , Cortelli, Pietro , Ehgoetz Martens, Kaylena , Gan‐Or, Ziv , Boeve, Angelica, Arnulf, Isabelle , Hu, Michele T M , Högl, Birgit , Sonka, Karel , Puligheddu, Monica , Heidbreder, Anna , Arnaldi, Dario

Mayo Clinic

Brain | January 26, 2019 | Volume: 142 | Issue: 3 | Pages: 744-759

10.1093/brain/awz030 | PMID 30789229 Get It

Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103.
O’Neill, Anne, Dang, Chau T. , Northfelt, Donald W. , Gradishar, William J. , Goldstein, Lori J. , Brufsky, Adam , Bloom, Stuart H. , Fox, Kevin R., Hendricks, Carolyn B., Balcueva, Ernie, Brufsky, Adam M , Miller, Kathy D. , Mayer, Ingrid A. , Sparano, Joseph A. , Tevaarwerk, Amyé , Sledge, George W.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 500-500

10.1200/jco.2014.32.15_suppl.500 Get It

CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rec
Lenz, Heinz‐Josef , Innocenti, Federico , Mahoney, Michelle R., O’Neil, Bert H. , Polite, Blasé N. , Höchster, Howard S. , Atkins, James N., Goldberg, Richard M. , Schilsky, Richard L. , Blanke, Charles D. , ECOG, Cancer and Leukemia Group B (Alliance), SWOG, and, Venook, Alan P. , Niedzwiecki, Donna , Shaw, James Edward , Mayer, Robert J. , Bertagnolli, Monica M. , ECOG, Cancer and Leukemia Group B (Alliance), SWOG, and

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: LBA3-LBA3

10.1200/jco.2014.32.15_suppl.lba3 Get It

Vitamin B12 (Vit B12) biochemical (BCH) deficiency (DEF) in non-diabetic breast cancer (BC) patients on NCIC CTG MA.32: A phase III randomized adjuvant BC trial comparing metformin (Met) to placebo (Pl).
Liebman, Mira, Brien, William, Parulekar, Wendy R. , Shepherd, Lois E. , Ligibel, Jennifer A. , Rastogi, Priya , Hobday, Timothy J. , Thompson, Alastair M. , Whelan, Timothy J. , Mukherjee, Som D., Chalchal, Haji , Bernstein, Vanessa , Gelmon, Karen A. , Hershman, Dawn L. , Mayer, Ingrid A. , Lemieux, Julie , Pritchard, Kathleen I. , Stambolic, Vuk , Chen, Bingshu E. , Goodwin, Pamela J.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 542-542

10.1200/jco.2014.32.15_suppl.542 Get It

Whole-exome sequencing (WES) of HER2+ metastatic breast cancer (MBC) from patients (pts) treated with prior trastuzumab (T): A correlative analysis of TBCRC003.
Wagle, Nikhil , Richardson, Andrea L. , Forero‐Torres, Andres , Hobday, Timothy J. , Dees, Elizabeth Claire , Nanda, Rita , Rimawi, Mothaffar F. , Barry, William T., Gabriel, Stacey B., Garraway, Levi A. , Krop, Ian E. , Rimawi, Mothaffar , Lin, Nancy U. , Leshchiner, Ignaty , Mayer, Ingrid A. , Wolff, Antonio C. , Winer, Eric P.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 536-536

10.1200/jco.2014.32.15_suppl.536 Get It